Psychotic Disorders: all 1,655 studies

Page 6 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on LurasidoneCompletedNCT01173874Phase 3Results posted
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderCompletedNCT01143090Phase 3Results posted
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsCompletedNCT01143077Phase 3Results posted
• A Comparison of Long-acting Injectable Medications for SchizophreniaCompletedNCT01136772Phase 4Results posted
• Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial SyndromeTerminatedNCT01127503Phase 2Results posted
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.TerminatedNCT01122927Phase 3Results posted
• A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)CompletedNCT01101464Phase 2Results posted
• Effects of Pravastatin on Cholesterol, Inflammation and Cognition in SchizophreniaCompletedNCT01082588Phase 4Results posted
• Nonconvulsive Electrotherapy: a Proof-of-concept TrialCompletedNCT01065597Phase 1Results posted
• Supported Employment: Motivational Enhancement for Entry and OutcomeCompletedNCT01041976Phase 2Results posted
• DECIFER: Depression and Citalopram In First Episode RecoveryCompletedNCT01041274Phase 4Results posted
• Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of SchizophreniaCompletedNCT01029769Not applicableResults posted
• Oxytocin Treatment of SchizophreniaCompletedNCT01028677Not applicableResults posted
• Treatment of Alcohol Dependence and Comorbid Bipolar DisorderCompletedNCT01015586Phase 4Results posted
• Vitamin D Supplementation in Psychiatric IllnessesCompletedNCT01004354Not applicableResults posted
• Remediation of Working Memory in SchizophreniaCompletedNCT00995553Not applicableResults posted
• An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00992407Phase 4Results posted
• Web-Based Delivery of MOVE! to Veterans With Serious Mental Illness (SMI)CompletedNCT00983476Not applicableResults posted
• Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With SchizophreniaCompletedNCT00981526Phase 4Results posted
• Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin ElevationTerminatedNCT00975611Phase 4Results posted
• Smoking Cessation for Veterans With Severe and Persistent Mental IllnessCompletedNCT00960375Phase 2/3Results posted
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic SymptomsTerminatedNCT00955474Phase 4Results posted
• Cannabis and Schizophrenia: Self-Medication and Agonist TreatmentCompletedNCT00946348Phase 1Results posted
• Mindfulness Meditation as a Rehabilitation Strategy for Persons With SchizophreniaCompletedNCT00936351Not applicableResults posted
• Treatment of Psychotic Major Depression With MifepristoneTerminatedNCT00867360Phase 3Results posted
• Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTerminatedNCT00857818Phase 3Results posted
• Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaCompletedNCT00833976Phase 4Results posted
• Biomarkers in SchizophreniaCompletedNCT00817336Phase 2Results posted
• Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With AntipsychoticsCompletedNCT00806234Phase 4Results posted
• Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in SchizophreniaCompletedNCT00797277Phase 3Results posted
• Pilot Trial of Naltrexone for Obesity in Women With SchizophreniaCompletedNCT00793780Not applicableResults posted
• Artemisinin to Reduce The Symptoms of SchizophreniaCompletedNCT00753506Not applicableResults posted
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• Pregnenolone for Cognitive and Negative Symptoms in SchizophreniaCompletedNCT00728728Phase 2Results posted
• Treatment of Schizoaffective Disorder Using MifepristoneTerminatedNCT00725270Phase 2/3Results posted
• Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight GainCompletedNCT00709202Phase 2Results posted
• Demonstrate the Effects of Pramlintide on Weight Reduction in SchizophreniaCompletedNCT00690235Phase 4Results posted
• Biomarker Study of Acamprosate in SchizophreniaCompletedNCT00688324Phase 4Results posted
• Cognitive-Behavioral Therapy in Veterans With SchizophreniaCompletedNCT00688259Not applicableResults posted
• Schizophrenic Patients in Integrated CareTerminatedNCT00681629Phase 4Results posted
• A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)CompletedNCT00677898Not applicableResults posted
• A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00658567Phase 3Results posted
• Effect of Single Dose Intranasal Insulin On Cognitive FunctionCompletedNCT00646581Phase 4Results posted
• Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With SchizophreniaCompletedNCT00645944Not applicableResults posted
• Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00644969Phase 3Results posted
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaCompletedNCT00641745Phase 3Results posted
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic FeaturesTerminatedNCT00637494Phase 3Results posted
• Ziprasidone in the Psychosis ProdromeCompletedNCT00635700Phase 2Results posted
• A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar DisorderCompletedNCT00621777Phase 4Results posted
• Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaCompletedNCT00595504Phase 4Results posted
• A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory PsychosisTerminatedNCT00591318Phase 1/2Results posted
• Cannabidiol Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00588731Phase 2Results posted
• First Episode Schizophrenia and Cannabis-Related Disorder StudyCompletedNCT00573287Not applicableResults posted
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive FunctioningCompletedNCT00566735Phase 3Results posted
• The Combination of Aripiprazole and Antidepressants in Psychotic Major DepressionCompletedNCT00556140Phase 3Results posted
• A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00550238Phase 3Results posted
• The Effects of Rimonabant, on Weight and Metabolic Risk FactorsTerminatedNCT00547118Phase 2Results posted
• High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to RisperidoneCompletedNCT00539071Phase 4Results posted
• Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to ZiprasidoneCompletedNCT00538642Not applicableResults posted
• Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseCompletedNCT00535145Phase 4Results posted
• Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
• Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.CompletedNCT00521365Phase 4Results posted
• Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)TerminatedNCT00517075Phase 2Results posted
• Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
• Illness Management and Recovery for Veterans With Severe Mental IllnessCompletedNCT00515671Not applicableResults posted
• Systematic Evaluation of Antiviral Medication in SchizophreniaCompletedNCT00514449Phase 2Results posted
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineCompletedNCT00512070Not applicableResults posted
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualCompletedNCT00498550Phase 4Results posted
• Varenicline Adjunctive Treatment in SchizophreniaCompletedNCT00492349Phase 4Results posted
• Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.CompletedNCT00488319Phase 3Results posted
• A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisCompletedNCT00477672Phase 3Results posted
• Improving Basic and Social Cognition in Veterans With SchizophreniaCompletedNCT00470106Not applicableResults posted
• The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.CompletedNCT00466323Not applicableResults posted
• Efficacy and Tolerability of Switching to Ziprasidone From Other AntipsychoticsCompletedNCT00458211Phase 4Results posted
• Effects of Pentazocine Versus Lorazepam on Manic SymptomsCompletedNCT00431184Phase 2Results posted
• Modafinil for Treatment of Cognitive Dysfunction in SchizophreniaCompletedNCT00423943Phase 4Results posted
• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
• Open-label Ziprasidone Study for Psychosis Treatment in AdolescentsCompletedNCT00421954Phase 3Results posted
• Antipsychotic Discontinuation in Alzheimer's DiseaseCompletedNCT00417482Phase 4Results posted
• Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.CompletedNCT00412373Phase 3Results posted
• Improving Adherence to Oral Antipsychotic Medications in People With SchizophreniaCompletedNCT00406718Not applicableResults posted
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedNCT00406315Phase 4Results posted
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineCompletedNCT00401973Phase 3Results posted
• Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.CompletedNCT00397033Phase 3Results posted
• Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00373672Phase 4Results posted
• A Definitive Estrogen Patch Study (ADEPT)CompletedNCT00357006Phase 2Results posted
• Clinical Trial of Dipyridamole in SchizophreniaCompletedNCT00349973Not applicableResults posted
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic DepressionCompletedNCT00340379Phase 2/3Results posted
• Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaCompletedNCT00337662Phase 4Results posted
• Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedNCT00330863Phase 4Results posted
• Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse DisorderCompletedNCT00316303Phase 2Results posted
• Optimizing Response in Psychosis StudyTerminatedNCT00314327Phase 4Results posted
• Specialized Treatment Early in Psychosis (STEP)CompletedNCT00309452Not applicableResults posted
• Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?CompletedNCT00306475Phase 4Results posted
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)CompletedNCT00303602Phase 4Results posted
• Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With SchizophreniaCompletedNCT00299702Phase 4Results posted
• Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance SyndromeCompletedNCT00288366Not applicableResults posted
• Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTerminatedNCT00288353Phase 3Results posted
• Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)CompletedNCT00281320Phase 3Results posted
• An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaCompletedNCT00269919Phase 4Results posted

← Psychotic Disorders overview